edotreotide has been researched along with Adenoma, beta-Cell in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hamasaki, A; Harashima, S; Inagaki, N; Nakamoto, Y; Shibue, K | 1 |
Breeman, WA; Sims-Mourtada, J; Smith, DL | 1 |
2 other study(ies) available for edotreotide and Adenoma, beta-Cell
Article | Year |
---|---|
[Case report; a case of gastorinoma with subclinical insulinoma presenting repeated episodes of hypoglycemic attack].
Topics: Adult; Humans; Hypoglycemia; Insulin; Insulinoma; Male; Octreotide; Pancreatic Neoplasms; Treatment Outcome | 2013 |
The untapped potential of Gallium 68-PET: the next wave of ⁶⁸Ga-agents.
Topics: Amine Oxidase (Copper-Containing); Cell Adhesion Molecules; Gallium Radioisotopes; Glucagon-Like Peptide 1; Half-Life; Insulinoma; Neuroendocrine Tumors; Octreotide; Oligopeptides; Organometallic Compounds; Positron-Emission Tomography; Radionuclide Generators; Radiopharmaceuticals; Receptors, Bombesin; Receptors, Somatostatin; Single-Domain Antibodies; Somatostatin; Vascular Endothelial Growth Factor A | 2013 |